OM
Outset Medical, Inc.
Outset Medical, Inc. insider trading
Insiders at Outset Medical, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Leonard Braden Michael (10% Owner) buying $806K of OM, filed Oct 05, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $870.3K
- Sold
- —
- Insiders
- 1
- Latest trade
- Oct 01, 2026
From SEC filings · last 30 days
Recent OM insider transactions
SEC Form 4 data, Q3 2024 to Q2 2026
OM insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 6 insiders traded OM on the open market: 0 purchases and 61 sales worth $659.3K. In the last four quarters alone: 0 purchases and 23 sales ($342.3K), by 5 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | −$115.7K4 sales | |
| Q1 2026 | — | −$193K12 sales | |
| Q4 2025 | — | −$13.9K4 sales | |
| Q3 2025 | — | −$19.7K3 sales | |
| Q2 2025 | — | −$38.6K4 sales | |
| Q1 2025 | — | −$252.5K25 sales | |
| Q4 2024 | — | −$11.6K4 sales | |
| Q3 2024 | — | −$14.3K5 sales |
- Largest sale
- −$87.3K of OM by Gaeta Renee (Chief Financial Officer) on Jun 03, 2026.
Open-market transactions through Jun 30, 2026most recent first
Gaeta Renee
Chief Financial Officer
−$87.3K
Jun 03, 2026
17,672 sh · $4.94
Trigg Leslie
Chair and CEO · Director
−$12.7K
May 15, 2026
3,445 sh · $3.70
Brottem John L.
General Counsel
−$9.8K
May 15, 2026
2,638 sh · $3.70
Nash Marc
EVP Operations R&D & Service
−$5.9K
May 15, 2026
1,582 sh · $3.70
Trigg Leslie
Chair and CEO · Director
−$11.3K
Feb 17, 2026
3,361 sh · $3.35
Brottem John L.
General Counsel
−$9.5K
Feb 17, 2026
2,842 sh · $3.35
Nash Marc
EVP Operations R&D & Service
−$6.1K
Feb 17, 2026
1,817 sh · $3.35
Trigg Leslie
Chair and CEO · Director
−$10.7K
Jan 21, 2026
2,120 sh · $5.05
Brottem John L.
General Counsel
−$5.9K
Jan 21, 2026
1,180 sh · $5.01
Nash Marc
EVP Operations R&D & Service
−$4.9K
Jan 21, 2026
980 sh · $4.98
Trigg Leslie
Chair and CEO · Director
−$60.4K
Jan 20, 2026
11,794 sh · $5.12
Brottem John L.
General Counsel
−$47.7K
Jan 20, 2026
9,314 sh · $5.12
Nash Marc
EVP Operations R&D & Service
−$27.5K
Jan 20, 2026
5,375 sh · $5.12
Trigg Leslie
Chair and CEO · Director
−$7.7K
Jan 07, 2026
1,795 sh · $4.27
Brottem John L.
General Counsel
−$956
Jan 07, 2026
224 sh · $4.27
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 03, 2026 | Gaeta ReneeChief Financial Officer | 17,672 | $4.94 | −$87.3K |
| May 15, 2026 | Trigg LeslieChair and CEO · Director | 3,445 | $3.70 | −$12.7K |
| May 15, 2026 | Brottem John L.General Counsel | 2,638 | $3.70 | −$9.8K |
| May 15, 2026 | Nash MarcEVP Operations R&D & Service | 1,582 | $3.70 | −$5.9K |
| Feb 17, 2026 | Trigg LeslieChair and CEO · Director | 3,361 | $3.35 | −$11.3K |
| Feb 17, 2026 | Brottem John L.General Counsel | 2,842 | $3.35 | −$9.5K |
| Feb 17, 2026 | Nash MarcEVP Operations R&D & Service | 1,817 | $3.35 | −$6.1K |
| Jan 21, 2026 | Trigg LeslieChair and CEO · Director | 2,120 | $5.05 | −$10.7K |
| Jan 21, 2026 | Brottem John L.General Counsel | 1,180 | $5.01 | −$5.9K |
| Jan 21, 2026 | Nash MarcEVP Operations R&D & Service | 980 | $4.98 | −$4.9K |
| Jan 20, 2026 | Trigg LeslieChair and CEO · Director | 11,794 | $5.12 | −$60.4K |
| Jan 20, 2026 | Brottem John L.General Counsel | 9,314 | $5.12 | −$47.7K |
| Jan 20, 2026 | Nash MarcEVP Operations R&D & Service | 5,375 | $5.12 | −$27.5K |
| Jan 07, 2026 | Trigg LeslieChair and CEO · Director | 1,795 | $4.27 | −$7.7K |
| Jan 07, 2026 | Brottem John L.General Counsel | 224 | $4.27 | −$956 |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check OM — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Outset Medical, Inc. is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are OM insiders buying or selling?
- Between Oct 02, 2026 and Oct 01, 2026, 1 Outset Medical, Inc. insider made 2 open-market purchases worth $870.3K and no sales, a net purchase of $870.3K.
- How much OM stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 6 Outset Medical, Inc. insiders made no open-market purchases and 61 sales worth $659.3K. In the four quarters to Jun 30, 2026: no purchases and 23 sales ($342.3K). The largest sale was Gaeta Renee selling $87.3K on Jun 03, 2026.
- What was the largest recent OM insider trade?
- Leonard Braden Michael (10% Owner) bought $806K of OM stock on Oct 01, 2026 at about $3.53 a share.
- When did an insider last buy OM shares?
- The most recent open-market purchase on file is Leonard Braden Michael (10% Owner) buying $64.2K on Oct 02, 2026. The largest purchase in the period was $806K by Leonard Braden Michael.
- Where does OM insider trading data come from?
- From the Form 4 filings Outset Medical, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.